Challenge-proven aspirin hypersensitivity in children with chronic spontaneous urticaria

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 2, 2015, Pages 153-160

  Cavkaytar, Ozlem ^a   Arik Yilmaz, Ebru ^a   Buyuktiryaki, Betul ^a   Sekerel, Bulent E ^a   Sackesen, Cansin ^a   Soyer, Ozge U ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

aspirin; chronic urticaria; drug allergy; nonsteroidal anti inflammatory drug

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; IBUPROFEN; METHYLPREDNISOLONE; PARACETAMOL; PLACEBO; SALBUTAMOL; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADOLESCENT DISEASE; ANGIONEUROTIC EDEMA; ARTICLE; CHILD; CHILDHOOD DISEASE; CHRONIC SPONTANEOUS URTICARIA; CHRONIC URTICARIA; CLINICAL FEATURE; DRUG HYPERSENSITIVITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LIP DISEASE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROVOCATION TEST; SCHOOL CHILD; SINGLE DRUG DOSE; THROMBOCYTE COUNT; ANGIOEDEMA; CHEMICALLY INDUCED; CHRONIC DISEASE; COMORBIDITY; DIAGNOSTIC USE; DISEASE COURSE; IMMUNOLOGICAL TOLERANCE; PROGNOSIS; URTICARIA;

ADOLESCENT; ANGIOEDEMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHILD; CHRONIC DISEASE; COMORBIDITY; DISEASE PROGRESSION; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; IMMUNE TOLERANCE; MALE; PROGNOSIS; URTICARIA;

EID: 84920804686     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12539     Document Type: Article

References (35)

1. Gomes ER, Demoly P,. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005; 5: 309-316.
2. Chen CJ, Cheng CF, Lin HY, Hung SP, Chen WC, Lin MS,. A comprehensive 4-year survey of adverse drug reactions using a network-based hospital system. J Clin Pharm Ther 2012; 37: 647-651.
3. Settipane RA, Constantine HP, Settipane GA,. Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review. Allergy 1980; 35: 149-154.
4. Botey J, Ibero M, Malet A, Marin A, Eseverri JL,. Aspirin-induced recurrent urticaria and recurrent angioedema in non-atopic children. Ann Allergy 1984; 53: 265-267.
5. Capriles-Behrens E, Caplin J, Sanchez-Borges M,. NSAID facial angioedema in a selected pediatric atopic population. J Investig Allergol Clin Immunol 2000; 10: 277-279.
6. Zambonino MA, Torres MJ, Munoz C, Requena G, Mayorga C, Posadas T, et al. Drug provocation tests in the diagnosis of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in children. Pediatr Allergy Immunol 2013; 24: 151-159.
7. Kowalski ML, Asero R, Bavbek S, Blanca M, Blanca-Lopez N, Bochenek G, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 2013; 68: 1219-1232.
8. Szczeklik A, Sanak M,. The broken balance in aspirin hypersensitivity. Eur J Pharmacol 2006; 533: 145-155.
9. Moore-Robinson M, Warin RP,. Effect of salicylates in urticaria. Br Med J 1967; 4: 262-264.
10. Mastalerz L, Setkowicz M, Sanak M, Szczeklik A,. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol 2004; 113: 771-775.
11. Grattan CE,. Aspirin sensitivity and urticaria. Clin Exp Dermatol 2003; 28: 123-127.
12. Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A,. Aspirin-exacerbated cutaneous disease. Immunol Allergy Clin North Am 2013; 33: 251-262.
13. Dills R, Anderson LA, Pierce CA,. The role of nonsteroidal anti-inflammatory drugs in pediatric patients. Pharmacol Res 2012; 65: 5-8.
14. Sanchez-Borges M, Capriles-Behrens E, Caballero-Fonseca F,. Hypersensitivity to nonsteroidal anti-inflammatory drugs in childhood. Pediatr Allergy Immunol 2004; 15: 376-380.
15. Mastalerz L, Setkowicz M, Szczeklik A,. Mechanism of chronic urticaria exacerbation by aspirin. Curr Allergy Asthma Rep 2005; 5: 277-283.
16. Greaves MW,. Chronic urticaria in childhood. Allergy 2000; 55: 309-320.
17. Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, et al. The EAACI/GA LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014; 69: 868-887.
18. Mlynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M,. How to assess disease activity in patients with chronic urticaria? Allergy 2008; 63: 777-780.
19. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Picado C, Scadding G, et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007; 62: 1111-1118.
20. Lee CRJ, Shilkofski N,. Drug doses. In:, Robertson JSN, editor. The Harriet Lane Handbook. Philadelphia: Elsevier Mosby; 2005: 679-1009.
21. Zembowicz A, Mastalerz L, Setkowicz M, Radziszewski W, Szczeklik A,. Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch Dermatol 2003; 139: 1577-1582.
22. Pacor ML, Di Lorenzo G, Corrocher R,. Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clin Exp Allergy 2001; 31: 1607-1614.
23. Asero R,. Etoricoxib challenge in patients with chronic urticaria with NSAID intolerance. Clin Exp Dermatol 2007; 32: 661-663.
24. Corzo JL, Zambonino MA, Munoz C, Mayorga C, Requena G, Urda A, et al. Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs. Br J Dermatol 2014; 170: 725-729.
25. Park HJ, Ye YM, Hur GY, Kim SH, Park HS,. Association between a TGFbeta1 promoter polymorphism and the phenotype of aspirin-intolerant chronic urticaria in a Korean population. J Clin Pharm Ther 2008; 33: 691-697.
26. Bae JS, Kim SH, Ye YM, Yoon HJ, Suh CH, Nahm DH, et al. Significant association of Fcepsilon RI alpha promoter polymorphisms with aspirin-intolerant chronic urticaria. J Allergy Clin Immunol 2007; 119: 449-456.
27. Asero R, Tedeschi A, Lorini M,. Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs. Ann Allergy Asthma Immunol 2002; 88: 468-472.
28. Kim SH, Ye YM, Lee SK, Park HS,. Genetic mechanism of aspirin-induced urticaria/angioedema. Curr Opin Allergy Clin Immunol 2006; 6: 266-270.
29. Zitelli KB, Cordoro KM,. Evidence-based evaluation and management of chronic urticaria in children. Pediatr Dermatol 2011; 28: 629-639.
30. Zhong H, Song Z, Chen W, Li H, He L, Gao T, et al. Chronic urticaria in Chinese population: a hospital-based multicenter epidemiological study. Allergy 2014; 69: 359-364.
31. Doeglas HM,. Reactions to aspirin and food additives in patients with chronic urticaria, including the physical urticarias. Br J Dermatol 1975; 93: 135-144.
32. Kidon MI, Kang LW, Chin CW, Hoon LS, See Y, Goh A, et al. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal anti-inflammatory drugs among young, Asian, atopic children. Pediatrics 2005; 116: e675-e680.
33. Yilmaz O, Ertoy Karagol IH, Bakirtas A, Topal E, Celik GE, Demirsoy MS, et al. Challenge-proven nonsteroidal anti-inflammatory drug hypersensitivity in children. Allergy 2013; 68: 1555-1561.
34. Setkowicz M, Mastalerz L, Podolec-Rubis M, Sanak M, Szczeklik A,. Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years. J Allergy Clin Immunol 2009; 123: 174-178.
35. Isik SR, Karakaya G, Celikel S, Demir AU, Kalyoncu AF,. Association between asthma, rhinitis and NSAID hypersensitivity in chronic urticaria patients and prevalence rates. Int Arch Allergy Immunol 2009; 150: 299-306.